On Oct. 26, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its Enforcement Report for Oct. 26, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On Oct. 25, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA added one new participant to its Voluntary Qualified Importer Program for the 2022/23 program year, bringing the total of participants in the trusted trader scheme for food importers to five, according to a recent update to the agency’s website. Hudson Trading Group joins Costco, Pacific Seafood, Palmex and Sovena, who also participated last year. In an emailed announcement, FDA said the VQIP portal will open Jan. 1 for applicants for participation in the 2023/24 program year that begins Oct. 1, 2023. The portal will remain open until May 31.
On Oct. 24, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 21, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 20, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Oct. 19, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA issued a guidance document Oct. 20 on the types of actions the agency will consider refusal of inspection by foreign food facilities and governments for the purposes of refusing food imports from those facilities. Under federal food safety laws, food from foreign facilities must be refused admission to the U.S. if the facility does not cooperate with FDA inspectors.
FDA has issued its Enforcement Report for Oct. 19, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.